DSCO (DSCO) Stock Price & Analysis
DSCO (DSCO) rose 0.12% to USD 24.76 as of July 25, 2026 at 20:52 UTC, according to Nexqual real-time market data.
DSCO last closed at USD 24.73; the session ranged USD 24.74–24.78 on volume of 8,610 shares. Market capitalization is —, with a 52-week range of USD 24.34–25.34 (PCX). Source: Nexqual, July 25, 2026 at 20:52 UTC.
Key Statistics (as of July 25, 2026 at 20:52 UTC)
| Price | USD 24.76 |
|---|---|
| Change | ▲ 0.12% (up) |
| Previous Close | USD 24.73 |
| Open | USD 24.75 |
| Day Range | USD 24.74 – 24.78 |
| 52-Week Range | USD 24.34 – 25.34 |
| Volume | 8,610 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (DSCO)
Nexqual's technical model rates DSCO "STRONG SELL" based on 0 bullish and 5 bearish signals across 120 daily candles, as of July 25, 2026 at 20:52 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 46.43 (neutral) |
| vs SMA50 | Below (USD 24.81) |
| MACD | -0.02 (negative) |
Financial Health Score (DSCO)
Nexqual rates DSCO's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 20:52 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GNTA | Genenta Science S.p.A. | USD 1.59 | ▼ 3.05% |
| CASIF | CASI Pharmaceuticals, Inc. | USD 0.13 | ▲ 0% |
| CBRX | Tradr 2X Long CBRS Daily ETF | USD 12.57 | ▼ 10.98% |
| DUSA | Davis Select U.S. Equity ETF | USD 56.93 | ▼ 0.85% |
| MEDX | Horizon Kinetics Medical ETF | USD 35.49 | ▲ 1.41% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 20:52 UTC. This page is informational and not investment advice.